Cargando…

The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys

The epidemiological characteristics of benign prostate hyperplasia (BPH) in mainland China are not completely understood. We performed this meta-analysis to assess the prevalence of BPH from 1989 through 2014. A total of 14 articles and 19 datasets were included. The pooled overall prevalence of BPH...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenying, Guo, Yuwen, Zhang, Daoxin, Tian, Ye, Zhang, Xiaonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549711/
https://www.ncbi.nlm.nih.gov/pubmed/26306721
http://dx.doi.org/10.1038/srep13546
_version_ 1782387350950641664
author Wang, Wenying
Guo, Yuwen
Zhang, Daoxin
Tian, Ye
Zhang, Xiaonan
author_facet Wang, Wenying
Guo, Yuwen
Zhang, Daoxin
Tian, Ye
Zhang, Xiaonan
author_sort Wang, Wenying
collection PubMed
description The epidemiological characteristics of benign prostate hyperplasia (BPH) in mainland China are not completely understood. We performed this meta-analysis to assess the prevalence of BPH from 1989 through 2014. A total of 14 articles and 19 datasets were included. The pooled overall prevalence of BPH among men aged 40 years and older was 36.6% [95% CI, 32.3–44.8]. The occurrence rate of BPH in the age groups 40–49 years, 50–59 years, 60–69 years, 70–79 years and 80 years and older was 2.9%, 29.0%, 44.7%, 58.1% and 69.2%, respectively. The pooled occurrence rate of BPH was 41.5% [95% CI, 34.5–48.4] in urban areas and 38.6% [95% CI, 22.7–54.6] in rural areas; this difference in prevalence was not statistically significant [OR, 1.51; 95% CI, 0.97–2.36]. BPH is highly prevalent in mainland China, and its prevalence increased with age. The trend in the prevalence of BPH in mainland China was not steady; the prevalence map based on a geographic information system (GIS) showed an unequal geographic distribution. High-quality surveys on BPH with a larger sample size are needed throughout mainland China to confirm these findings.
format Online
Article
Text
id pubmed-4549711
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-45497112015-09-04 The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys Wang, Wenying Guo, Yuwen Zhang, Daoxin Tian, Ye Zhang, Xiaonan Sci Rep Article The epidemiological characteristics of benign prostate hyperplasia (BPH) in mainland China are not completely understood. We performed this meta-analysis to assess the prevalence of BPH from 1989 through 2014. A total of 14 articles and 19 datasets were included. The pooled overall prevalence of BPH among men aged 40 years and older was 36.6% [95% CI, 32.3–44.8]. The occurrence rate of BPH in the age groups 40–49 years, 50–59 years, 60–69 years, 70–79 years and 80 years and older was 2.9%, 29.0%, 44.7%, 58.1% and 69.2%, respectively. The pooled occurrence rate of BPH was 41.5% [95% CI, 34.5–48.4] in urban areas and 38.6% [95% CI, 22.7–54.6] in rural areas; this difference in prevalence was not statistically significant [OR, 1.51; 95% CI, 0.97–2.36]. BPH is highly prevalent in mainland China, and its prevalence increased with age. The trend in the prevalence of BPH in mainland China was not steady; the prevalence map based on a geographic information system (GIS) showed an unequal geographic distribution. High-quality surveys on BPH with a larger sample size are needed throughout mainland China to confirm these findings. Nature Publishing Group 2015-08-26 /pmc/articles/PMC4549711/ /pubmed/26306721 http://dx.doi.org/10.1038/srep13546 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Wang, Wenying
Guo, Yuwen
Zhang, Daoxin
Tian, Ye
Zhang, Xiaonan
The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_full The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_fullStr The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_full_unstemmed The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_short The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
title_sort prevalence of benign prostatic hyperplasia in mainland china: evidence from epidemiological surveys
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549711/
https://www.ncbi.nlm.nih.gov/pubmed/26306721
http://dx.doi.org/10.1038/srep13546
work_keys_str_mv AT wangwenying theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys
AT guoyuwen theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys
AT zhangdaoxin theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys
AT tianye theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys
AT zhangxiaonan theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys
AT wangwenying prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys
AT guoyuwen prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys
AT zhangdaoxin prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys
AT tianye prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys
AT zhangxiaonan prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys